155 related articles for article (PubMed ID: 25471474)
1. Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs.
Taenzler J; Wengenmayer C; Williams H; Fourie J; Zschiesche E; Roepke RK; Heckeroth AR
Parasit Vectors; 2014 Dec; 7():567. PubMed ID: 25471474
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fluralaner flavored chews (Bravecto) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production.
Dryden MW; Smith V; Bennett T; Math L; Kallman J; Heaney K; Sun F
Parasit Vectors; 2015 Jul; 8():364. PubMed ID: 26160349
[TBL] [Abstract][Full Text] [Related]
3. Comparative speed of efficacy against Ctenocephalides felis of two oral treatments for dogs containing either afoxolaner or fluralaner.
Beugnet F; Liebenberg J; Halos L
Vet Parasitol; 2015 Jan; 207(3-4):297-301. PubMed ID: 25564276
[TBL] [Abstract][Full Text] [Related]
4. The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs.
Taenzler J; Gale B; Zschiesche E; Roepke RK; Heckeroth AR
Parasit Vectors; 2016 May; 9(1):233. PubMed ID: 27241021
[TBL] [Abstract][Full Text] [Related]
5. Comparative speed of kill of sarolaner (Simparica and fluralaner (Bravecto) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Liebenberg J; Honsberger NA; Mahabir SP
Parasit Vectors; 2016 Feb; 9():92. PubMed ID: 26896436
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.
Six RH; Becskei C; Carter L; Gale B; Young DR; Mahabir SP; Chapin S; Myers MR
Vet Parasitol; 2016 May; 222():23-7. PubMed ID: 26961589
[TBL] [Abstract][Full Text] [Related]
7. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs.
Kryda K; Mahabir SP; Carter L; Everett WR; Young DR; Meyer L; Thys M; Chapin S; Holzmer SJ; Becskei C
Parasit Vectors; 2020 Mar; 13(1):57. PubMed ID: 32113466
[TBL] [Abstract][Full Text] [Related]
8. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations.
Meadows C; Guerino F; Sun F
Parasit Vectors; 2014 Aug; 7():375. PubMed ID: 25129395
[TBL] [Abstract][Full Text] [Related]
9. A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment.
Ranjan S; Young D; Sun F
Parasit Vectors; 2018 Jul; 11(1):385. PubMed ID: 29970135
[TBL] [Abstract][Full Text] [Related]
10. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
Rohdich N; Roepke RK; Zschiesche E
Parasit Vectors; 2014 Mar; 7():83. PubMed ID: 24593931
[TBL] [Abstract][Full Text] [Related]
11. Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Everett WR; Myers MR; Mahabir SP
Parasit Vectors; 2016 Feb; 9():93. PubMed ID: 26896448
[TBL] [Abstract][Full Text] [Related]
12. Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto Quantum™) against repeated infestations with Rhipicephalus sanguineus (sensu lato) and Ctenocephalides felis in dogs.
Fisara P; Guerino F
Parasit Vectors; 2023 Oct; 16(1):378. PubMed ID: 37872632
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs.
Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S
Parasit Vectors; 2017 Nov; 10(1):529. PubMed ID: 29089019
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA.
Dryden MW; Canfield MS; Kalosy K; Smith A; Crevoiserat L; McGrady JC; Foley KM; Green K; Tebaldi C; Smith V; Bennett T; Heaney K; Math L; Royal C; Sun F
Parasit Vectors; 2016 Jun; 9(1):365. PubMed ID: 27352607
[TBL] [Abstract][Full Text] [Related]
15. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Ctenocephalides felis on dogs.
Six RH; Liebenberg J; Honsberger NA; Mahabir SP
Parasit Vectors; 2016 Feb; 9():90. PubMed ID: 26896428
[TBL] [Abstract][Full Text] [Related]
16. The sustained speed of kill of ticks (Rhipicephalus sanguineus) and fleas (Ctenocephalides felis felis) on dogs by a spot-on combination of fipronil and permethrin (Effitix
Cvejić D; Schneider C; Neethling W; Hellmann K; Liebenberg J; Navarro C
Vet Parasitol; 2017 Aug; 243():52-57. PubMed ID: 28807310
[TBL] [Abstract][Full Text] [Related]
17. Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment.
Williams H; Young DR; Qureshi T; Zoller H; Heckeroth AR
Parasit Vectors; 2014 Jun; 7():275. PubMed ID: 24946811
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
Six RH; Geurden T; Packianathan R; Colgan S; Everett WR; Grace S; Hodge A; Mahabir SP; Myers MR; Slootmans N; Davis K
Vet Parasitol; 2016 May; 222():18-22. PubMed ID: 26935820
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto
Fisara P; Guerino F; Sun F
Parasit Vectors; 2019 May; 12(1):259. PubMed ID: 31122282
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs.
Hunter JS; Dumont P; Chester TS; Young DR; Fourie JJ; Larsen DL
Vet Parasitol; 2014 Apr; 201(3-4):207-11. PubMed ID: 24629423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
